IL6 and ovarian cancer: A restriction endonuclease EcoRI assisted bio-platform prepared by Meftah et al. was used to determine polymorphisms in both interleukin-6 (IL6) and transforming growth factor β1 (TGFβ1) genes from patients suffered from ovarian cancer (Fig. 8a) (Meftah et al. 2023).